Keyword: Propeller Health
The move represents a big win for Propeller Health, which has a chance to provide its sensor-enabled inhaler and app to a large group of patients.
Propeller Health is launching an API, as well as a series of tools based on it, that provides information on local asthma conditions.
GlaxoSmithKline and Propeller Health are expanding their R&D partnership, inked in 2015, into a commercial one.
Propeller Health is teaming up with Novartis to develop a custom add-on sensor for the Big Pharma’s Breezhaler inhaler. The tie-up marks Propeller’s fifth pharma partnership and its third with a major respiratory disease player.
Propeller Health is teaming up with Medical International Research to integrate a number of MIR’s mobile and clinical spirometers into its digital respiratory disease management platform.
Propeller Health scored an FDA clearance for the use of its digital respiratory disease management system with GlaxoSmithKline’s dry powder inhaler, Ellipta. The clearance comes after the duo teamed up on “smart inhaler” tech back in December 2015.
Propeller Health snatched up $21.5 million in Series C financing that will drive the expansion of its digitally guided therapy platform.